Hologic (HOLX) Positive Trends Reversing - Piper Jaffray

Piper Jaffray analyst William Quirk reiterated an Overweight rating and $49.00 price target on Hologic (NASDAQ: HOLX) after his eBay channel checks suggest the positive trends in earlier research have reversed with more used Cynosure lasers hitting 3rd party websites and prices trending down.

The analyst stated "We recognize Cynosure represents just ~10% of Hologic's total revenue, but it carries a heavy psychological burden on the share price. Accordingly, we believe shares may have topped out in the immediate term. We maintain our 12 month OW rating, but recognize investors may be able to add to positions with the release of the March quarter results if our checks prove accurate".

For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.

Shares of Hologic closed at $44.26 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'